Ahmedabad, India

Milan B Agrawal

This inventor holds 1 USPTO granted patent. Top assignee: Piramal Enterprises Limited. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Milan B Agrawal. Retrieved from https://idiyas.com/inventor/milan-b-agrawal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Milan B Agrawal: Innovator in Pharmaceutical Composition

Introduction

Milan B Agrawal is a notable inventor based in Ahmedabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral compositions. His work focuses on improving the efficacy and delivery of medications.

Latest Patents

Milan holds a patent for an oral pharmaceutical composition of lurasidone and its preparation. This invention relates to a tablet formulation that includes lurasidone or its pharmaceutically acceptable salts or solvates, along with one or more pharmaceutical excipients. The process for preparing this composition is also detailed in his patent.

Career Highlights

Milan is currently associated with Piramal Enterprises Limited, a leading company in the pharmaceutical sector. His role involves research and development, where he applies his expertise to create innovative solutions in drug formulation.

Collaborations

Milan has worked alongside talented colleagues such as Tejas Shah and Narendra Patel. Their collaborative efforts contribute to the advancement of pharmaceutical technologies and innovations.

Conclusion

Milan B Agrawal's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions, particularly in the formulation of lurasidone, highlight the importance of research and development in creating effective medications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…